Surgery Partners, Inc. Ownership
$14.71
0.68%
Nasdaq, Oct 19, 04:00 pm EDT.
Closed.
Index
Industry
Surgery Partners, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Bain Capital Private Equity, LP
|
49.947m | 38.16% | — | Jun 30 2026 |
| 2 |
Janus Henderson Investors
|
13.882m | 10.61% | +341.770k | Jun 30 2026 |
| 3 |
Pentwater Capital Management LP
|
11.630m | 8.89% | -1.025m | Jun 30 2026 |
| 4 |
UBS Financial Services, Inc.
|
8.374m | 6.40% | -1.652m | Jun 30 2026 |
| 5 |
King Street Capital Management, L.P.
|
6.058m | 4.63% | -4.172m | Jun 30 2026 |
|
1
Bain Capital Private Equity, LP
|
38.16%
49.947m
|
|
2
Janus Henderson Investors
|
10.61%
13.882m
|
|
3
Pentwater Capital Management LP
|
8.89%
11.630m
|
|
4
UBS Financial Services, Inc.
|
6.40%
8.374m
|
|
5
King Street Capital Management, L.P.
|
4.63%
6.058m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 68.68% of Surgery Partners, Inc., with Bain Capital Private Equity, LP the biggest at 38.16%, followed by Janus Henderson Investors (10.61%) and Pentwater Capital Management LP (8.89%). |
Recent Surgery Partners, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 20 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 17 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 13 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Oct 08 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Oct 02 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 25 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 20 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 17 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 13 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Oct 08 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Oct 02 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 25 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Surgery Partners, Inc. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Surgery Partners, Inc. has held steady at around 21.7% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
